Logo of Huzzle

Intern, DMPK – Oligonucleotide Discovery/Development

Applications are closed

  • Internship
    Full-time
    Summer Internship
  • Science
  • San Francisco

Requirements

  • BS, MS, or PhD candidate in Drug Metabolism, Pharmacokinetics, Chemistry, or related scientific discipline.
  • Proficiency in wet lab techniques and experimental design is essential.
  • Strong desire to learn new techniques, such as automation, solid phase extraction, liquid chromatography, and mass spectrometry, with a dedicated commitment to continuous learning and skill development. Experience and knowledge with interpreting high-resolution mass spectral data is highly desired.
  • Demonstrated critical thinking and scientific skills, and excellent oral presentation and written communication skills.

Responsibilities

  • Acquire and interpret high-resolution mass spectral data to characterize the catabolism pathways of candidate oligonucleotides in vitro and in vivo.
  • Develop and optimize high-throughput oligonucleotide assays using a robotic system to enhance efficiency and accuracy.
  • Interact with multi-disciplinary project teams to design and conduct in vitro and in vivo DMPK studies to characterize oligonucleotides.
  • Adapt existing approaches, develop and confirm new strategies, for ADME assays that fit the specific needs of oligonucleotide projects.
  • Delivering presentations during and at the conclusion of your internship experience, summarizing research and recommendations; audiences will include colleagues within and outside of the DMPK/Development Sciences

Defeat Degeneration

Science & Healthcare
Industry
201-500
Employees
2015
Founded Year

Mission & Purpose

Denali Therapeutics is dedicated to defeating neurodegenerative diseases by breaking through historical barriers in scientific research and clinical development in order to deliver safe and effective medicines to patients and families. Our scientific approach is based on three core principles: rigorous assessment of genetic targets, engineering brain delivery, and using biomarkers to guide development. Our team thrives in a work environment that is scientifically driven, impact-focused, supportive, and collaborative. Our ability to have a positive impact on people’s lives is directly related to the trust we have in each other and our ability to unify our diverse backgrounds and experience behind our purpose to defeat degeneration.